Interferon alpha 2a downregulates VEGF expression through PI3 kinase and MAP kinase signaling pathways

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00432-004-0615-2PMID 15662525PMCID PMC12161216
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MAP Kinases and Hypoxia in the Control of VEGF Expression

  2004cited by this paper
• Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma.

  2003cited by this paper
• Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor.

  2003cited by this paper
• EphA2 Up-regulation induced by deoxycholic acid in human colon carcinoma cells, an involvement of extracellular signal-regulated kinase and p53-independence

  2003cited by this paper
• Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha.

  2002cited by this paper
• Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray

  2002cited by this paper
• Expression of HIF‐1α by human macrophages: implications for the use of macrophages in hypoxia‐regulated cancer gene therapy

  2002cited by this paper
• Induction of Vascular Endothelial Growth Factor by IGF-I in Osteoblast-Like Cells Is Mediated by the PI3K Signaling Pathway through the Hypoxia-Inducible Factor-2α.

  2002cited by this paper
• Cytotoxicity of IFN-gamma and TNF-alpha for vascular endothelial cell is mediated by nitric oxide.

  2002cited by this paper
• Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.

  2002cited by this paper
• Transforming growth factor‐β and Ras regulate the VEGF/VEGF‐receptor system during tumor angiogenesis

  2002cited by this paper
• Cytotoxicity of IFN-γ and TNF-α for Vascular Endothelial Cell Is Mediated by Nitric Oxide☆

  2002cited by this paper
• Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-Ras.

  2002cited by this paper
• Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts.

  2001cited by this paper
• Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research.

  2001cited by this paper
• Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.

  2001cited by this paper
• Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.

  2001cited by this paper
• Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.

  2001cited by this paper
• Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway

  2001cited by this paper
• Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice.

  2001cited by this paper
• Regulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products*

  2001cited by this paper
• Interaction of cytokines and growth factor in the regulation of verotoxin‐induced apoptosis in cultured human endothelial cells

  2001cited by this paper
• Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression

  2001cited by this paper
• Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.

  2001cited by this paper
• Angiopoietin-1, Unlike Angiopoietin-2, Is Incorporated into the Extracellular Matrix via Its Linker Peptide Region*

  2001cited by this paper
• Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.

  2001cited by this paper
• Differential expression of angiopoietin‐1 and angiopoietin‐2 in colon carcinoma

  2001cited by this paper
• Vascular endothelial growth factor (VEGF) expression regulates angiogenesis accompanying tumor growth in a peritoneal disseminated tumor model.

  2001cited by this paper
• Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.

  2001cited by this paper
• Endotoxins induce and interferon‐α suppresses vascular endothelial growth factor (VEGF) production in human peripheral blood mononuclear cells

  2001cited by this paper
• Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.

  2001cited by this paper
• Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.

  2001cited by this paper
• PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways.

  2001cited by this paper
• Angiogenesis Research: Guidelines for Translation to Clinical Application

  2001cited by this paper
• Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20.

  2000cited by this paper
• IkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2.

  2000cited by this paper
• Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors.

  2000cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Role of rab GDP dissociation inhibitor alpha in regulating plasticity of hippocampal neurotransmission.

  2000cited by this paper
• Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.

  2000cited by this paper
• RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F.

  2000cited by this paper
• The role of peroxisome proliferator-activated receptor gamma in bladder cancer in relation to angiogenesis and progression.

  2000cited by this paper
• Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus

  2000cited by this paper
• Endothelin-1 induces vascular endothelial growth factor synthesis in osteoblasts: involvement of p38 mitogen-activated protein kinase.

  2000cited by this paper
• Expression of basic fibroblast growth factor protein and its down‐regulation by interferons in head and neck cancer

  2000cited by this paper
• Norepinephrine Induces Vascular Endothelial Growth Factor Gene Expression in Brown Adipocytes through a β-Adrenoreceptor/cAMP/Protein Kinase A Pathway Involving Src but Independently of Erk1/2*

  2000cited by this paper
• Signaling Angiogenesis via p42/p44 MAP Kinase Cascade

  2000cited by this paper
• High‐lose and long‐term therapy with interferon‐alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential

  2000cited by this paper
• TNP‐470 and recombinant human interferon‐α2a inhibit angiogenesis synergistically

  2000cited by this paper
• The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitors.

  2000cited by this paper
• IκBα and IκBα/NF-κB Complexes Are Retained in the Cytoplasm through Interaction with a Novel Partner, RasGAP SH3-binding Protein 2*

  2000cited by this paper
• Vascular Endothelial Growth Factor Up-regulation via p21-activated Kinase-1 Signaling Regulates Heregulin-β1-mediated Angiogenesis*

  2000cited by this paper
• Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells.

  2000cited by this paper
• Inhibition of fibronectin-activated migration of microvascular endothelial cells by interleukin-1alpha, tumour necrosis factor alpha and interferon gamma.

  1999cited by this paper
• New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis

  1999cited by this paper
• INHIBITION OF FIBRONECTIN-ACTIVATED MIGRATION OF MICROVASCULAR ENDOTHELIAL CELLS BY INTERLEUKIN-1α, TUMOUR NECROSIS FACTOR α AND INTERFERON γ

  1999cited by this paper
• Interferon-alpha-induced inhibition of B16 melanoma cell proliferation: interference with the bFGF autocrine growth circuit.

  1999cited by this paper
• New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF

  1999cited by this paper
• Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.

  1999cited by this paper
• Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor.

  1998cited by this paper
• Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.

  1998cited by this paper
• Expression of platelet‐derived endothelial cell growth factor in bladder carcinoma

  1997cited by this paper
• Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.

  1997cited by this paper
• Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element.

  1997cited by this paper
• Interaction of Shc with Adaptor Protein Adaptins (*)

  1996cited by this paper
• Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues

  1996cited by this paper
• Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray

  1995cited by this paper
• cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain.

  1995cited by this paper
• A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain.

  1993cited by this paper
• Inhibition of angiogenesis.

  1992cited by this paper
• 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.

  1992cited by this paper
• 13-cis-Retinoic Acid and Interferon α -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin

  1992cited by this paper
• Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.

  1987cited by this paper
• Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors

  1972cited by this paper

• CXCL10 promotes melanoma angiogenesis and tumor growth

  2024cites this paper
• Thrombotic thrombocytopenic purpura in a patient on long-term alpha-interferon therapy for essential thrombocythemia: a case report

  2023cites this paper
• In Vitro Evaluation of Apoptosis, Inflammation, Angiogenesis, and Neuroprotection Gene Expression in Retinal Pigmented Epithelial Cell Treated with Interferon α-2b

  2023cites this paper
• Nephrotic-range proteinuria and membranoproliferative glomerulonephritis-like pattern caused by interferon-β1b in a patient with multiple sclerosis

  2022cites this paper
• The role of microenvironment in tumor angiogenesis

  2020cites this paper
• Interferons: pathogenetic rationale for the treatment of external genital endometriosis and clinical efficacy

  2019cites this paper
• Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer

  2017cites this paper
• Thrombotic microangiopathy caused by interferon β-1b for multiple sclerosis: a case report

  2016cites this paper
• FOR THE DEGREE OF DOCTOR OF PHILOSOPHY ( PHD ) INVESTIGATION OF POTENTIAL MECHANISMS INVOLVED IN THE ANTI-INFLAMMATORY EFFECTS OF APOPTOTIC CELLS by A NNA P

  2016cites this paper
• Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.

  2015cites this paper
• Protein-protein conjugation using interferon

  2015cites this paper
• Interferon-α enhances the susceptibility of renal cell carcinoma to rapamycin by suppressing mTOR activity

  2014cites this paper
• Chemotherapeutic Agents for the Treatment of Hepatocellular Carcinoma: Efficacy and Mode of Action

  2014cites this paper
• pathway for premature atherosclerosis promotes abnormal vasculogenesis in lupus: a potential α Interferon-

  2013cites this paper
• PTK787/ZK222584 Combined with Interferon Alpha and 5-Fluorouracil Synergistically Inhibits VEGF Signaling Pathway in Hepatocellular Carcinoma

  2013cites this paper
• Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.

  2012cites this paper
• Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma

  2012cites this paper
• Metastasis of Hepatic Cancer

  2012cites this paper
• Targeting the Endothelin Axis with Atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma

  2012cites this paper
• Type I Interferons and the Development of Impaired Vascular Function and Repair in Human and Murine Lupus

  2011cites this paper
• A 7-year-old with pulmonary hypertension

  2011cites this paper
• Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy

  2011cites this paper
• Interferon in Kaposi’s Sarcoma Biology and Therapy

  2010cites this paper
• Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus‐related liver cancer

  2010cites this paper
• Molecular Events on Metastasis of Hepatocellular Carcinoma

  2010cites this paper
• The Detrimental Effects of IFN-α on Vasculogenesis in Lupus Are Mediated by Repression of IL-1 Pathways: Potential Role in Atherogenesis and Renal Vascular Rarefaction

  2010cites this paper
• Interferon, Cytokine Induction, and other Potential In Vivo Toxicities

  2010cites this paper
• Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells.

  2010cites this paper
• Bacillary angiomatosis after skin autografting in a patient without human immunodeficiency virus who was treated with interferon alfa.

  2010cites this paper
• Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth.

  2009cites this paper
• siRNA and Innate Immunity

  2009cites this paper
• Interferon Alpha‐2a Reduces Early Erythema After Full‐Thickness Skin Graft in the Pig

  2009cites this paper
• STAT1 represses hypoxia-inducible factor-1-mediated transcription.

  2009cites this paper
• Premature vascular damage in systemic lupus erythematosus

  2009cites this paper
• Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1.

  2009cites this paper
• Postoperative Interferon Alpha Treatment of Patients with Hepatocellular Carcinoma: Expression of p48 Using Tissue Microarray

  2009cites this paper
• Targeted agents for the systemic treatment of advanced hepatocellular carcinoma

  2009cites this paper
• Targeted therapies for the systemic treatment of advanced hepatocellular carcinoma

  2009cites this paper
• Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro‐angiogenic and prometastatic factors in murine liver fibrosis

  2008cites this paper
• Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularization.

  2008cites this paper
• Präklinische Studien zum Einfluss des Tyrosinkinaseinhibitors AEE788 auf die Malignität des Nierenzellkarzinoms

  2008cites this paper
• Intracerebral Cavernous Hemangioma after Cranial Irradiation in Childhood

  2008cites this paper
• Overcoming the Innate Immune Response to Small Interfering RNA

  2008cites this paper
• The pathogenesis of pterygium: current concepts and their therapeutic implications.

  2008cites this paper
• Impact of Interferon Therapy after Curative Treatment of Hepatocellular Carcinoma

  2008cites this paper
• [Preclinical studies on the influence of the tyrosine kinase inhibitor AEE788 on malignant properties of renal cell carcinoma cells].

  2008cites this paper
• VEGF Secretion is Inhibited by Interferon-Alpha in Several Melanoma Cell Lines

  2008cites this paper
• Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.

  2008cites this paper
• Interferon-α promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis

  2007cites this paper
• Modulation the Effect of Interferon by Diverse Protein Kinase Inhibitors

  2007cites this paper
• Combined intra‐arterial 5‐fluorouracil and subcutaneous interferon‐alpha therapy for highly advanced hepatocellular carcinoma

  2007cites this paper
• Cell-specific but p53-independent Regulation of Vascular Endothelial Growth Factor Expression by Interferons in Human Glioblastoma Cells

  2006cites this paper
• Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages.

  2006cites this paper
• Management of solitary palatal metastasis from renal cell carcinoma

  2006cites this paper
• Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages.

  2006cites this paper
• P48 is a predictive marker for outcome of postoperative interferon‐α treatment in patients with hepatitis B virus infection‐related hepatocellular carcinoma

  2006cites this paper
• Norepinephrine but not hypoxia stimulates HIF-1alpha gene expression in brown adipocytes.

  2005cites this paper
• Treatment of Basal Cell Carcinoma Located in the Head and Neck Region with Intralesional Interferon α-2a

  2005cites this paper
• Treatment of Basal Cell Carcinoma Located in the Head and Neck Region with Intralesional Interferon alpha-2a : Evaluation of Long-Term Follow-Up Results.

  2005cites this paper
• Modulation of gene expression in MHCC97 cells by interferon alpha.

  2005cites this paper
• Vascular Endothelial Growth Factor in Thyroid Cancers

  2005cites this paper